Lys216

Site Information
LEELGNHkAFKkELR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 3883218

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Relevant cell line - cell type - tissue:	brain ( 1 , 2 , 3 , 4 , 5 , 6 )

References
1	Guo A (2008) CST Curation Set: 3970; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
2	Guo A (2008) CST Curation Set: 3971; Year: 2008; Biosample/Treatment: tissue, brain/Reperfusion; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
3	Guo A (2008) CST Curation Set: 3972; Year: 2008; Biosample/Treatment: tissue, brain/Reperfusion; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
4	Guo A (2007) CST Curation Set: 3574; Year: 2007; Biosample/Treatment: tissue, brain/mock surgery; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
5	Guo A (2007) CST Curation Set: 3573; Year: 2007; Biosample/Treatment: tissue, brain/mock surgery; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
6	Guo A (2007) CST Curation Set: 3578; Year: 2007; Biosample/Treatment: tissue, brain/ischemia &'\|\|' Reperfusion; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info